YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Pfizer Rebuffed by AstraZeneca, Regroups


April 22, 2014 | Talks between Pfizer and AstraZeneca fizzled, but the possibility foretells future big deals, says Bloomberg. Some analysts expect Pfizer to approach AstraZeneca again soon, while others expect a merger between AstraZeneca and another peer-sized pharma like Amgen. If AZ continues to decline Pfizer's offer, the world's biggest drugmaker may have backup plans. Bloomberg
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.